Wednesday, 22 October, 2008 Orthomimetics, the Cambridge based medical device company, continues to broaden its product portfolio with a third grant of Government funding. This £600,000 Technology Strategy Board (TSB) grant will support an R&D project for improving joint tissue regeneration. It is based on the use of a combination cell therapy technique with OM's tissue specific 3-D scaffolds. More...
Wednesday, 10 September, 2008 Orthomimetics Limited has announced the appointment of Dr Anthony Miniaci MD of the Cleveland Clinic and Professor László Hangody of Uzsoki Hospital to its Medical Advisory Board. Professor Hangody and Dr Miniaci join Professor Neil Rushton of the University of Cambridge on the Orthomimetics Medical Advisory Board to provide the Cambridge, UK-based designer and manufacturer of regenerative medical implants with input into its clinical and product-development programmes. More...
Wednesday, April 09, 2008 OrthoMimetics, the developer of novel regenerative medicine approaches for cartilage and ligament repair, joined other successful businesses at the Cambridge News Business Awards Ceremony held at King’s College, Cambridge, and overcame strong competition to win the ‘Rising Star’ category. More...
Wednesday, January 23, 2008A consortium led by OrthoMimetics (OM) has been awarded £747k ($1.5m) from the UK Technology Strategy Board (TSB) for the commercial development of LigaMimetic, the second product based on OM’s technology platform. More...
Sunday, June 17, 2007Athletes could soon have access to new technology for helping repair cartilage with a medical device being developed by Cambridge-based OrthoMimetics Limited. More...
Tuesday, December 05, 2006OrthoMimetics Limited, the first technology spin-out from the Cambridge-MIT Institute, has completed a Series A funding round totalling £5.0m ($9.6m) net of costs. More...
Tuesday, May 30, 2006 A revolutionary technology to help reduce the need for joint replacement surgery has been developed by a team of surgeons, scientists and engineers from the University of Cambridge and MIT. More...
Friday, March 31, 2006 OrthoMimetics was formed in 2005 as the first spin-out venture from the Cambridge-MIT Institute to address the problem of limited lifetimes of joint replacements, a $30 billion industry. More...
Thursday, December 15, 2005 In recent years, a number of universities have created graduate degrees in biotech and business. Although it's still too early to measure their value, it appears that they are already inspiring debate and some startup activity. More...
Thursday, November 24, 2005 OrthoMimetics, the first technology spin-out to emerge from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding. More...
Friday, November 18, 2005 Three companies were successful in securing investment funding (subject to contract) from CREATE in the East of England Development Agency's running the gauntlet competition for entrepreneurs. More...
Wednesday, November 16, 2005 The first technology company to emerge from the collaboration between the University of Cambridge and the Massachusetts Institute of Technology (MIT) has made it to the finals of a prestigious entrepreneurship contest. More...
Tuesday, November 15, 2005 The first technology company to emerge from the collaboration between the University of Cambridge and the Massachusetts Institute of Technology (MIT) has made it to the finals of a prestigious entrepreneurship contest. More...
Monday, October 31, 2005 Ten companies from across the East of England are through to the final of the East of England Development Agency (EEDA) running the gauntlet business competition – giving them the chance of securing a share of £1m in investment funding and £200,000 of in-kind business services. More...
Tuesday, September 13, 2005 Fifty entrepreneurs are in line for a share of £1 million of investment funding after being short listed in the UK's biggest business competition. More...